Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + Temozolomide + Irinotecan in Unresectable Glioblastoma
NCT00979017Phase 2Completed
- Sponsor
- Katy Peters
- Start
- Nov 2009
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of bevacizumab in glioblastoma multiforme (GBM) and Gliosarcoma (GS), sponsored by Katy Peters. Started Nov 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
glioblastoma multiforme (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00979017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979017.